Kiniksa Pharmaceuticals International, plc KNSA Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's short-term investments?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported short-term investments of $278.14M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's short-term investments changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's short-term investments increased by 150.1% year-over-year, from $111.21M to $278.14M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's short-term investments?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's short-term investments has grown at a 3.5% compound annual growth rate (CAGR), from $209.44M to $248.48M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.